
원본
Thermo Fisher Scientific EIF2A Recombinant Rabbit Monoclonal Antibody (ARC1712)
상품 한눈에 보기
EIF2A 단백질 검출용 토끼 단클론 항체로 Western blot, IHC, ELISA에 사용 가능. 인간, 마우스, 랫트 반응성. HEK293 세포 발현, 친화 크로마토그래피 정제. -20°C 보관, 연구용 전용.
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 03. 오후 07:31
카탈로그 번호 · 상품 설명출고판매가담기
Thermo Fisher Scientific MA538202 EIF2A Recombinant Rabbit Monoclonal Antibody (ARC1712) 100 ul pk판매 단위 pk ·
재고 확인 필요
699,900원VAT 포함 769,890원
Thermo Fisher Scientific · Thermo Fisher Scientific EIF2A Recombinant Rabbit Monoclonal Antibody (ARC1712)
Applications and Tested Dilutions
| Application | Tested Dilution |
|---|---|
| Western Blot (WB) | 1:500–1:1,000 |
| Immunohistochemistry (Paraffin) (IHC (P)) | 1:200–1:2,000 |
| ELISA | 1 µg/mL |
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human, Mouse, Rat |
| Host / Isotype | Rabbit / IgG |
| Expression System | HEK293 cells |
| Class | Recombinant Monoclonal |
| Type | Antibody |
| Clone | ARC1712 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 450–550 of human eIF2A (Q9BY44) |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 0.5 mg/mL |
| Purification | Affinity chromatography |
| Storage Buffer | PBS, pH 7.3, with 50% glycerol, 0.05% BSA |
| Contains | 0.02% sodium azide |
| Storage Conditions | –20°C, Avoid Freeze/Thaw Cycles |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
| RRID | AB_2898119 |
Product Specific Information
- Positive Samples: BxPC-3, Mouse liver, Rat lung
- Immunogen sequence:
ALRNKPITNS KLHEEEPPQN MKPQSGNDKP LSKTALKNQR KHEAKKAAKQ EARSDKSPDL APTPAPQSTP RNTVSQSISG DPEIDKKIKN LKKKLKAIEQ L
Target Information
EIF2A is a 65-kD protein that catalyzes the formation of puromycin-sensitive 80S preinitiation complexes.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
